|
Market Closed -
Nasdaq Stockholm
20:00:00 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 7.360 SEK | 0.00% |
|
+4.55% | +31.43% |
| 08-20 | Mendus AB, Q2 2026 Earnings Call, Aug 20, 2026 | |
| 08-20 | Mendus AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MENDUS AB | Other Biotechnology & Medical Research | 0.00% | +4.55% | +31.43% | +5.14% | -92.37% | 51.02M |  | |  |
- Stock Market
- Stocks
- IMMU Stock
- Charts Mendus AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
